Item 5.02 Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On March 14, 2022, IQVIA Holdings Inc. (the "Company") announced the appointment
of Costa Panagos as President of its Research & Development Solutions ("R&DS")
business unit, effective April 1, 2022. Mr. Panagos has more than 25 years of
industry experience serving life sciences customers and managing contract
research organizations. Mr. Panagos joined the company in 1999 and has held
numerous sales, operational and executive leadership positions across the
Company. Mr. Panagos currently serves as President, Research & Development
Operations, where he is responsible for the global delivery of all clinical
trials, including traditional full-service trials, decentralized clinical trials
and flexible staffing arrangements. Prior to his current role, Mr. Panagos
served as chief executive officer of Q2 Solutions, the Company's global clinical
trial laboratory business. Before joining the Company, Mr. Panagos held various
roles in the pharmaceutical division of Bayer. Mr. Panagos earned a bachelor's
degree in Biology from Brown University and an MBA from the University of
Chicago Booth School of Business.
On this same date, the Company announced that Richard Staub III, President,
R&DS, will retire from his current role effective April 1, 2022 but will remain
with the Company as a senior advisor to the Chief Executive Officer (the "CEO")
to play an important role in business development efforts, serve on customer
governance boards, and ensure a smooth transition. In Mr. Staub's role as Senior
Advisor to the CEO, he will receive compensation commensurate with this new
role.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
Exhibit No. Description
99.1 Press release dated March 14, 2022
104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
--------------------------------------------------------------------------------
© Edgar Online, source Glimpses
IQVIA HOLDINGS INC. 
